Taiyen Biotech (1737.TW) Earnings Analysis

Taiyen Biotech (1737.TW) has no confirmed upcoming earnings date. Trailing P/E 16.16.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 1737.TW next report earnings?

No confirmed upcoming earnings date is currently scheduled for 1737.TW. This page updates as the calendar is published.

1737.TW earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-040.47 TWDn/an/an/a
2026-03-090.72 TWDn/an/an/a
2025-11-060.36 TWDn/an/an/a
2025-07-280.43 TWDn/an/an/a
2025-03-100.3778 TWDn/an/an/a
2024-11-080.458 TWDn/an/an/a
2024-07-290.4938 TWDn/an/an/a

1737.TW valuation and analyst view

Trailing P/E16.16
Trailing EPS1.976 TWD
Price / book0.93
Dividend yield4.06%
Market cap6.36B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Taiyen Biotech (1737.TW)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 1737.TW. This page updates as the calendar is published.

Did 1737.TW beat earnings last quarter?

Consensus estimate data was not available for 1737.TW's 2026-05-04 report.

What is 1737.TW's current P/E ratio and EPS?

1737.TW trades at a trailing P/E of 16.16 on trailing EPS of 1.9756282032144101 TWD.

What do analysts rate 1737.TW?

1737.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.